Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 55, 103169
Abstract
No abstract availableKeywords
Funding Information
- Emory University
- School of Medicine, Emory University
- National Institutes of Health (UL1TR002378)
This publication has 19 references indexed in Scilit:
- Neurologic and Radiographic Findings Associated With COVID-19 Infection in ChildrenJAMA Neurology, 2020
- Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2–associated encephalitisNeurology Neuroimmunology & Neuroinflammation, 2020
- Psychotic symptoms in COVID-19 patients. A retrospective descriptive studyPsychiatry Research, 2020
- Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020Emerging Infectious Diseases, 2020
- Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reportsJournal of Neuroinflammation, 2020
- The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findingsBrain, 2020
- Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemicThe Lancet Psychiatry, 2020
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- Steroid‐Responsive Encephalitis in Coronavirus Disease 2019Annals of Neurology, 2020
- Neurofilaments in disease: what do we know?Current Opinion in Neurobiology, 2020